Resistance to antivascular endothelial growth factor treatment in age-related macular degeneration
Paris Tranos,1 Athanasios Vacalis,1 Solon Asteriadis,1 Stavrenia Koukoula,1 Athanasios Vachtsevanos,1 Georgia Perganta,1 Ilias Georgalas21Retina Centre, Thessaloniki, Greece; 2Department of Ophthalmology, "G Gennimatas" Hospital of Athens, University of Athens, Athens, GreeceAbstract: Age-...
Main Authors: | Tranos P, Vakalis A, Asteriadis S, Koukoula S, Vachtsevanos A, Perganta G, Georgalas I |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2013-06-01
|
Series: | Drug Design, Development and Therapy |
Online Access: | http://www.dovepress.com/resistance-to-antivascular-endothelial-growth-factor-treatment-in-age--a13357 |
Similar Items
-
Antivascular Endothelial Growth Factor Agents for Neovascular Age-Related Macular Degeneration
by: Ilias Zampros, et al.
Published: (2012-01-01) -
Use of antivascular endothelial growth factor for diabetic macular edema
by: Rushmia Karim, et al.
Published: (2010-05-01) -
Repeated intravitreal injections of antivascular endothelial growth factor in patients with neovascular age-related macular degeneration may increase the risk of ischemic optic neuropathy
by: Yu-Yen Chen, et al.
Published: (2019-12-01) -
Real-world outcomes of intravitreal antivascular endothelial growth factors for neovascular age-related macular degeneration in Taiwan: A 4-year longitudinal study
by: Benjamin Chi-Lan Yang, et al.
Published: (2019-01-01) -
Comparing vision and macular thickness in neovascular age-related macular degeneration, diabetic macular oedema and retinal vein occlusion patients treated with intravitreal antivascular endothelial growth factor injections in clinical practice
by: Rajya L Gurung, et al.
Published: (2021-07-01)